ArticleFrontiers in immunology2021

Treatment With Endothelin-A Receptor Antagonist BQ123 Attenuates Acute Inflammation in Mice Through T-Cell-Dependent Polymorphonuclear Myeloid-Derived Suppressor Cell Activation.

Ziyang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.